Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 229

1.

Chronic immune thrombocytopenic purpura in children: assessment of rituximab treatment.

Wang J, Wiley JM, Luddy R, Greenberg J, Feuerstein MA, Bussel JB.

J Pediatr. 2005 Feb;146(2):217-21.

PMID:
15689912
2.

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.

Braendstrup P, Bjerrum OW, Nielsen OJ, Jensen BA, Clausen NT, Hansen PB, Andersen I, Schmidt K, Andersen TM, Peterslund NA, Birgens HS, Plesner T, Pedersen BB, Hasselbalch HC.

Am J Hematol. 2005 Apr;78(4):275-80.

3.

Treatment of chronic immune thrombocytopenic purpura with rituximab in children.

Dogan M, Oner AF, Acikgoz M, Uner A.

Indian J Pediatr. 2009 Nov;76(11):1141-4.

PMID:
20092026
4.

Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients.

Peñalver FJ, Jiménez-Yuste V, Almagro M, Alvarez-Larrán A, Rodríguez L, Casado M, Gallur L, Giraldo P, Hernández R, Menor D, Rodríguez MJ, Caballero D, González R, Mayans J, Millán I, Cabrera JR; Multi-institutional Retrospective Spanish Study Group on the Use of Rituximab in Refractory ITP..

Ann Hematol. 2006 Jun;85(6):400-6. Epub 2006 Mar 21. Erratum in: Ann Hematol. 2006 Aug;85(8):558. Dosage error in article text.

PMID:
16550390
5.

The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura.

Cooper N, Stasi R, Cunningham-Rundles S, Feuerstein MA, Leonard JP, Amadori S, Bussel JB.

Br J Haematol. 2004 Apr;125(2):232-9.

PMID:
15059147
6.

Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias.

Rao A, Kelly M, Musselman M, Ramadas J, Wilson D, Grossman W, Shenoy S.

Pediatr Blood Cancer. 2008 Apr;50(4):822-5.

PMID:
17570702
7.

Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results.

Medeot M, Zaja F, Vianelli N, Battista M, Baccarani M, Patriarca F, Soldano F, Isola M, De Luca S, Fanin R.

Eur J Haematol. 2008 Sep;81(3):165-9. doi: 10.1111/j.1600-0609.2008.01100.x. Epub 2008 May 27.

PMID:
18510702
8.

Rituximab treatment for symptomatic chronic ITP.

Tamminga RY, Bruin MC.

Pediatr Blood Cancer. 2006 Oct 15;47(5 Suppl):714-6. Review.

PMID:
16933264
9.

Predicting response to splenectomy in children with immune thrombocytopenic purpura.

Wood JH, Partrick DA, Hays T, Ziegler MM.

J Pediatr Surg. 2010 Jan;45(1):140-4; discussion 144. doi: 10.1016/j.jpedsurg.2009.10.026.

PMID:
20105594
10.

Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.

Schweizer C, Reu FJ, Ho AD, Hensel M.

Ann Hematol. 2007 Oct;86(10):711-7. Epub 2007 Jul 11.

PMID:
17622529
11.

Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study.

Godeau B, Porcher R, Fain O, Lefrère F, Fenaux P, Cheze S, Vekhoff A, Chauveheid MP, Stirnemann J, Galicier L, Bourgeois E, Haiat S, Varet B, Leporrier M, Papo T, Khellaf M, Michel M, Bierling P.

Blood. 2008 Aug 15;112(4):999-1004. doi: 10.1182/blood-2008-01-131029. Epub 2008 May 7.

12.

Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study.

Giagounidis AA, Anhuf J, Schneider P, Germing U, Söhngen D, Quabeck K, Aul C.

Eur J Haematol. 2002 Aug;69(2):95-100.

PMID:
12366712
13.

Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment.

Parodi E, Nobili B, Perrotta S, Rosaria Matarese SM, Russo G, Licciardello M, Zecca M, Locatelli F, Cesaro S, Bisogno G, Giordano P, De Mattia D, Ramenghia U.

Int J Hematol. 2006 Jul;84(1):48-53.

PMID:
16867902
14.

A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia.

Saleh MN, Gutheil J, Moore M, Bunch PW, Butler J, Kunkel L, Grillo-López AJ, LoBuglio AF.

Semin Oncol. 2000 Dec;27(6 Suppl 12):99-103.

PMID:
11226008
15.

Effect of a single dose of rituximab in chronic immune thrombocytopenic purpura in childhood.

Taube T, Schmid H, Reinhard H, von Stackelberg A, Overberg US.

Haematologica. 2005 Feb;90(2):281-3.

16.

[Rituximab treatment of chronic idiopathic thrombocytopenic purpura. Results of a phase II study].

Meo P, Stipa E, La Presa M, Bianchi M, Di Giulio C, Stasi R, Amadori S.

Recenti Prog Med. 2002 Jul-Aug;93(7-8):421-7. Italian.

PMID:
12138687
17.

Platelet and immune responses to oral cyclic dexamethasone therapy in childhood chronic immune thrombocytopenic purpura.

Kühne T, Freedman J, Semple JW, Doyle J, Butchart S, Blanchette VS.

J Pediatr. 1997 Jan;130(1):17-24.

PMID:
9003846
18.

One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximab.

Mueller BU, Bennett CM, Feldman HA, Bussel JB, Abshire TC, Moore TB, Sawaf H, Loh ML, Rogers ZR, Glader BE, McCarthy MC, Mahoney DH, Olson TA, Feig SA, Lorenzana AN, Mentzer WC, Buchanan GR, Neufeld EJ; Pediatric Rituximab/ITP Study Group.; Glaser Pediatric Research Network..

Pediatr Blood Cancer. 2009 Feb;52(2):259-62. doi: 10.1002/pbc.21757.

PMID:
18937333
19.

Should rituximab be used before or after splenectomy in patients with immune thrombocytopenic purpura?

Cooper N, Evangelista ML, Amadori S, Stasi R.

Curr Opin Hematol. 2007 Nov;14(6):642-6. Review.

PMID:
17898569
20.

Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained response.

Parodi E, Rivetti E, Amendola G, Bisogno G, Calabrese R, Farruggia P, Giordano P, Matarese SM, Nardi M, Nobili B, Notarangelo LD, Russo G, Vimercati C, Zecca M, De Mattia D, Ramenghi U.

Br J Haematol. 2009 Feb;144(4):552-8. doi: 10.1111/j.1365-2141.2008.07487.x. Epub 2008 Nov 22.

PMID:
19036077

Supplemental Content

Support Center